Wound Closure Devices Market Size Worth $22.98 Billion By 2026

The global wound closure devices market size is expected to reach USD 22.98 billion by 2026, expanding at a CAGR of 7.1%, according to a new report by Grand View Research, Inc. Increasing prevalence of chronic injuries, technological advancements, and rising number of road accidents and surgeries are expected to propel market growth.

Rising incidence of road accidents across the globe has led to increase in demand for various wound closure devices. For instance, as per the reports on Road Traffic Injuries by WHO, every year 20 million to 50 million people suffer from some kind of injuries or disabilities resulting from road accidents. Moreover, increasing prevalence of burn and trauma cases globally is anticipated to drive the market. For instance, as per WHO (2018), around 1,000,000 people suffer from severe or moderate burns in India, each year. In addition, as per the National Center for Biotechnology Information (NCBI), in 2017, countries such as Bulgaria, Finland, the Netherlands, and China reported a rise in incidence of burn injuries. Wound closure devices, such as adhesives, staples, and sutures, are required for the treatment of such injuries.

North America held the largest market share in 2018 owing to the presence of key players in the region. Rising awareness among patients regarding the benefits of surgeries in providing quick relief from pains is driving regional growth. Key players operating in the North America market include B. Braun Melsungen AG; 3M; Medtronic; Johnson & Johnson Services, Inc.; and Baxter. The Asia Pacific market is expected to exhibit the fastest growth rate over the forecast period owing to surge of medical tourism.

Some of the products offered by key players are STRATAFIX suture by Johnson & Johnson, TISSEELfibrin sealant by Baxter, Biatain Adhesive and Biatain Ag Adhesive by Coloplast Corp., and APPOSE Single Use Skin Stapler by Medtronic.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/wound-closure-devices-market

Further key findings from the study suggest:

On the basis of product, sutures held the largest market share in 2018 owing to rising number of surgeries and increasing incidence road accidents, burn cases, and trauma events across the globe
The hospital segment held the largest market share in 2018 owing to surge in the number of cosmetic and plastic surgeries
The acute wound segment held the dominant market share in 2018, driven by increasing number of burn cases across the globe
The Asia Pacific wound closure devices market is anticipated to witness the fastest growth over the forecast period thanks to rising medical tourism in this region and increasing healthcare expenditure
Prominent players in the market include 3M; Johnson & Johnson Services, Inc.; B. Braun Melsungen AG; Medtronic; Baxter; Integra LifeSciences Corporation; and Smith & Nephew.

Powered Surgical Instruments Market Size Worth $2.8 Billion By 2026

The global powered surgical instruments market size is expected to reach USD 2.8 billion by 2026, according to a new report by Grand View Research, Inc., exhibiting a CAGR of 3.8%. Increasing number of surgical procedures, coupled with technological advancements, is anticipated to drive the market. Moreover, increasing awareness and affordability of plastic or reconstructive surgeries and surgeries for sports injuries is likely propel growth over the forecast period.

Increase in factors such as demand for minimally invasive surgeries & robot-aided procedures as well as improving accessibility to healthcare is contributing to growth. In addition, increasing geriatric population and rising awareness about availability of surgical procedures are likely to boost the market.

Increase in number of road accidents and rising healthcare expenditure in emerging economies are other factors likely to boost revenue generation in the market. According to the U.S. Census Bureau, the global healthcare expenditure is expected to reach USD 18.28 trillion by 2040, growing at a CAGR of 2.6%. According to WHO, the global population aged 60 years and above is expected to reach 2 billion by 2050, from 900 million in 2015. This demographic is more susceptible to a vast number of diseases, increasing the need for effective treatments, thereby boosting the market.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/powered-surgical-instruments-market

Further key findings from the study suggest:

North America accounted for the largest share of over 42.0%, owing to high prevalence of chronic disorders, favorable reimbursement policies, presence of key players, and government initiatives.
Asian countries are estimated to show the highest growth rate of 5% over the forecast period, due to an increasing adoption of advanced technologies, increasing investments, improving reimbursement scenario, and increasing medical tourism.
Handpiece powered surgical instruments is expected to dominate over the forecast period. It accounted for more than more than 40.0% of share in 2018.
Based on application, orthopedic, followed by cardiovascular surgery, were leading segments in the market, owing to high use of powered instruments, rising geriatric population, and growing incidence of osteoporosis and heart conditions.
Key players in powered surgical instruments market are opting for strategies, such as partnerships & acquisitions, introduction of new products, and investments in new technologies, to expand their product portfolio and to strengthen global footprint. For instance, in November 2018, Stryker Corporation announced acquisition of K2M Group Holdings, Inc., thereby expanding its product portfolio.

Cancer Diagnostics Market Worth $249.6 Billion By 2026

The global cancer diagnostics market size is expected to reach USD 249.6 billion by 2026, according to a new report by Grand View Research, Inc., exhibiting a 7.0% during the forecast period. Continual introduction of innovative products, coupled with increasing need for early diagnosis of various diseases, is a prime factor driving the market. In addition, rapid growth of the healthcare and diagnostics sector can be attributed to penetration of technologically advanced laboratory systems that have improved oncological screening in yielding accurate outcomes. Rising incidence of cancer is triggering demand for these screening tests and imaging modalities used for monitoring disease progression.

Collaborative and independent initiatives led by governments and companies are striving to raise cognizance about the benefits of early cancer diagnosis. In addition, cancer research organizations, along with public and private entities, are investing heavily on research projects to launch advanced diagnostic tools in the market, which are capable of diagnosing the disease much before the symptoms appear.

Furthermore, giant players are collaborating with governments and other agencies to enhance patient accessibility to these tests and products. For instance, Illumina, Inc. launched a new venture called GRAIL with investors, Jeff Bezos and Bill Gates, with an investment of more than USD 100 million. GRAIL is mainly focused on blood-based oncological screening for timely diagnosis of the most common tumor types through simple laboratory tests.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/cancer-diagnostics-market

Further key findings from the report suggest:

Rapid adoption of technology and escalating need for early diagnosis is augmenting the growth of imaging systems. Thus, the segment is expected to exhibit the fastest CAGR at 8.0% during the forecast period
The breast cancer segment accounted for the largest share based on application due to high incidence rate of breast cancer triggering the need for its early diagnosis
In 2018, North America dominated the global space with the largest revenue share of 42.0%. Focused research efforts in oncology for development of early tumor detection tools, coupled with grants from government healthcare agencies, are contributing to a strong medical ecosystem to fight cancer in this region
Asia Pacific is expected to emerge as the fastest growing region during the forecast period. Favorable regulatory framework and growing patient pool in India, China, and Japan due to support in diagnostic process at comparatively lower prices are some of the factors boosting the market growth in this region
Major players competing in this market include GE Healthcare; Abbott; Hoffmann-La Roche Ltd.; and Siemens Healthcare GmbH. Other prominent players include but are not limited to Becton Dickinson & Company; Illumina, Inc.; Koninklijke Philips N.V.; and Hologic, Inc.

Endoscopy Devices Market Worth $58.1 Billion By 2025

The global endoscopy devices market size is expected to reach USD 58.1 billion by 2025, according to a new report by Grand View Research, Inc., exhibiting a CAGR of 7.4% during the forecast period. Growing preference for minimally invasive endoscopic procedures, increasing geriatric population, and increase in prevalence of target gynecological, urological, & gastrointestinal diseases are key factors contributing to market growth. Technological advancements in endoscopes and visualization systems are also positively impacting the market.

High demand for endoscopes, visualization systems in diagnostics, and therapeutics for various target diseases plays a vital role in increasing revenue. Growing preference for minimally invasive surgical alternatives, such as laparoscopy, hysteroscopy, and colonoscopy, to open surgeries is reinforcing demand for endoscopic devices. The shift toward minimally invasive procedures can attributed to the associated benefits, such as better patient satisfaction, economic viability, relatively shorter hospital stays, and reduced postsurgical complications. Growth of the market can also be attributed to increasing preference for HD visualization systems by healthcare professionals, due to their better imaging capabilities. They help in diagnosis and treatment of complex diseases, such as cancer, GI disorders, lung disorders, and urinary disorders and are minimally invasive.

Availability of technologically advanced devices, such as HD visualization systems, robot-assisted endoscopes, disposable endoscopes, and HD resolution camera heads is also driving the market. Market players such as Stryker Corporation, Olympus Corporation, and Ethicon Endo-Surgery, LLC are investing on R&D to improve existing products along with launch of new products, which is expected to drive the endoscopy devices market further. For instance, in 2016, Olympus launched the VISERA 4K UHD surgical system equipped with a 55-inch primary operative HD display, to enhance minimally invasive surgical procedures. It also launched a 3D surgical endoscope in June 2017, which was compatible with the VISERA ELITE II HD imaging system. In March 2018, Auris Health, Inc. received FDA approval for the Monarch Platform-a new robotic endoscopic system. This platform uses 3D imaging to facilitate depth perception, thereby enabling high precision in surgeries.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/endoscopy-devices-market

Further key findings from the report suggest:

By product, endoscopy visualization systems emerged as the largest product segment in 2018, with a revenue share of 42.7%
By application, gastrointestinal endoscopy accounted for the largest revenue share in 2018. Meanwhile, urological endoscopy is expected to grow at the fastest CAGR over the forecast period
Hospitals emerged as the leading end-use segment, while ambulatory surgery centers is expected to show a significant growth rate
North America accounted for the largest market, due to a favorable reimbursement framework, high disease prevalence, growing geriatric population, and rapid adoption of minimally invasive endoscopic procedures
Asia Pacific is anticipated to show a lucrative CAGR of 8.6% over the forecast period, owing to substantial economic growth, high prevalence of cancer, improvement in healthcare infrastructure, and increase in awareness about minimally invasive surgeries
Olympus Corporation; Fujifilm Holdings Corporation; Ethicon Endo-Surgery, LLC; Stryker Corporation; Medtronic; Richard Wolf Gmbh; Boston Scientific Corporation; Karl Storz; and CONMED Corporation are leading players.

Personalized Medicine Market Size Worth $3.18 Trillion By 2025

The global personalized medicine (PM) market size is expected to reach USD 3.18 trillion by 2025 registering a CAGR of 10.6% over the forecast period, according to a new report by Grand View Research, Inc. Growing number of approved companion diagnostics and biomarker products have been proved promising avenues for the development of advanced precision diagnostic tests. Several personalized diagnostics and therapeutic products based on companion diagnostics are under clinical trials and development pipelines, which also add an incremental opportunity to accelerate this market.

Gene therapies are widely utilized to diagnose both chronic and genetic disorders according to individual’s genetic makeup. Growing adoption of gene sequencing and data analytics technologies is anticipated to escalate precision medicine market growth. Decreasing cost of whole genome sequencing, advancement in cell biology sector, and the development of “Human Genome Project” are several other factors influencing the demand for gene therapy hence, boosting the overall market. Moreover, key leaders are undergoing numerous strategic developments to launch novel personalized products, which will also contribute to the market expansion.

For instance, in September 2018, Vertex Pharmaceuticals collaborated with Genomics for the delivery of precision medicine based on individual’s genetic differences and lifestyle. Similarly, in January 2018, Foundation Medicine collaborated with European Organization for Research and Treatment of Cancer (EORTC) to facilitate Foundation’s comprehensive genomic profiling to across personalized medicine and clinical trial enrolment.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/personalized-medicine-market

Further key findings from the study suggest:

PM therapeutics is projected to register the fastest CAGR over the forecast period owing to the development of high-capacity rapid sequencing platforms for medical therapies
Reduction in sequencing cost leads to an expected growth of genomic sequencing and genetic research, thus contributing to lucrative opportunities for genomic medicine
Asia Pacific is projected to be the fastest-growing regional market due to rising number of collaborative initiatives between eastern and western market leaders
Chinese personalized medicine market is benefitted due to initiatives implemented by the Chinese government and reimbursements for disease treatment
Prominent companies include GE Healthcare; Illumina, Inc.; Asuragen, Inc.; Abbott Laboratories; Dako A/S; Exact Science Corp.; and Biogen, Inc.

Audiology Devices Market Worth $15.5 Billion By 2026

The global audiology devices market size is expected to reach USD 15.5 billion by 2026 registering a CAGR of 5.8%, according to a new report by Grand View Research, Inc. Increasing cases of hearing disorders, especially in geriatric population, rising purchasing capacity, investments in R&D, and government support for better healthcare infrastructure are expected to drive the market over the forecast period.

High comfort offered by newly introduced devices, improved connectivity, and better user interface are some of the factors attributing to high usage rate of audiology devices. Better quality of life along with acceptance of digital hearing aids are anticipated to further drive the market. In a study published in January 2019, it was observed that hearing aids reduce symptoms associated with dementia. However, usage is hampered due to the exclusion of hearing aids or exams for fitting hearing aids from the Original Medicare program.

Hearing aids segment led the market in 2018 and will hold its leading position in future. However, cochlear implants is expected to be the fastest-growing segment over the forecast period. Cochlear implants are widely used owing to their high effectiveness, in terms of sentence understanding.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/audiology-devices-market

Further key findings from the report suggest:

Digital hearing aids led the technology segment in terms of market share in 2018 due to their increased adaptability and connectivity with mobile devices
Retail sales channel was the dominant segment in 2018 and is projected to expand further at the fastest CAGR during the forecast period
North America dominated the global audiology devices market in 2018 due to technological advancements and presence of major market participants in the region
Asia Pacific is anticipated to witness the fastest CAGR owing to improving healthcare infrastructure along with growing geriatric population in emerging countries, such as India and China
Key industry participants include GN ReSound Group;William Demant Holdings A/S; Starkey Hearing Technologies; Widex A/S; Sonova Holdings AG; Phonak, Audioscan; MedRx; Austar Hearing; National Hearing Care; and NHC/Amplifon

Computational Biology Market Size Worth $13.6 Billion By 2026

The global computational biology market size is expected to reach USD 13.6 billion by 2026, according to a new report by Grand View Research, Inc. It is anticipated to expand at a CAGR of 21.3% during the forecast period. Rise in clinical studies in pharmacokinetics and pharmacogenomics for novel drug delivery and increase in the application of computational biology for bioinformatics R&D programs for the population based sequencing studies are fueling the market growth.

Unrecognizable scientific researcher is initiating an artificial intelligence application in a computing network. Science and technology metaphor for neuroscience, AI, biochemistry and drug research.

Rising use of computational tools in genomics, epi-genomics, proteomics, and meta-genomics to understand 3D protein structural analysis, protein-protein interactions, and gene sequencing and expression studies coupled with increasing research activities in drug designing and disease modeling is expected to drive the growth. However, lack of skilled resources to operate computational tools is expected to restrain the growth of the computational biology market during the forecast period.

Many pharmaceutical companies are seeking funding from angel investors. For instance, in February 2019, StemoniX Inc., the U.S. based provider of product and services for drug discovery and development, received funding of USD 14.40 million from a group of investors. Brightstone Venture Capital was the major financer and was later joined by Crescent Ridge Partners, Alumni Ventures Group, and Mayo Clinic. Similarly, in the same month, U.S. based Buffalo Niagara Medical Campus received funding of USD 5.0 million to speed up the discovery of new drugs. With this finding, the research institute is planning to procure and install drug discovery research instruments and other drug discovery platforms.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/computational-biology-market

Further key findings from the report suggest:

Cellular and biological simulation is expected to expand at the fastest CAGR of over 15.0% over the forecast period. The shift in sequencing studies towards further analysis of the nature of various biological proteins as a part of the development of personalized medicine, is projected drive the growth
Drug discovery and disease modelling applications led the market, accounting for 38.0% of the global market in terms of revenue in 2018. The factors responsible for this growth are extensive drug pipelines for the global drug manufacturing firms
North America was the largest regional market, accounted for more than 45.0% of the global revenue in 2018. Increase in research activities for drug discovery processes and innovations in biological computation tools are anticipated to drive the growth
Asia Pacific is anticipated to witness the fastest of around CAGR of 23.0% during the forecast period, due to increasing expenditure in the clinical studies for the pharmaco-kinetics and pharmaco-genomics
Some of the players operating in the computational biology market include Chemical Computing Group Inc.; Compugen Ltd.; Simulation Plus Inc.; Genedata AG; Certara; Insilico Biotechnology AG; Accelrys; Rhenovia Pharma SAS; Entelos; Nimbus Discovery LLC; and Rhenovia Pharma SAS.

Coconut Products Market Worth $95.64 Billion By 2025

The global coconut products market size is expected to reach USD 95.64 billion by 2025, according to a new report by Grand View Research, Inc. It is anticipated to expand at a CAGR of 17.8% during the forecast period. The market is expected to witness significant growth due to rapidly rising consumption in countries from Europe and North America. Various health benefits and applications of coconut products are anticipated to further fuel the adoption.

Coconut oil accounted for the largest market share owing to its various applications in cosmetics, food and beverages, energy, and oil and gas among other industries. Moreover, manufacturers are also focusing on finding innovative applications of this product. The strictly vegan population prefers coconut milk as one of the alternatives to dairy milk. However, due to a recent study conducted by a Harvard epidemiologist, consumption of coconut oil can be harmful due its high saturated fat content which can increase level of bad cholesterol in the body. In addition to this study, increasing use of other oils like almond and soy is expected to hinder the segment growth. Coconut water is the fastest growing segment owing to the rising awareness regarding its benefits among major European countries. Currently, the product is being used as a substitute to energy drinks like Gatorade. Hence key market players are focusing on the untapped potential benefits of the product to create growth opportunities.

Cosmetics industry was the largest consumer of coconut products in 2018, owing to booming cosmetics market coupled with consumer preference for organic and natural cosmetics. The segment is anticipated to witness the fastest CAGR of 18.1% from 2019 to 2025. Food and beverages industry from Asia Pacific and Central and South America is anticipated to register significant consumption of coconut products. These regions are the major producers of coconut and hence these products are commonly included in daily use. However, due to the availability of many alternatives such as almond oil, soy products, and rice milk among others, this segment is anticipated to grow at a steady pace. Other applications of coconut products are being explored in the textile industry as geo-textiles and in the energy sector as biofuels.

North America held the highest market share in terms of revenue in 2018, due to increasing consumer preference for plant-based products. Europe is anticipated to showcase substantial growth in light of increasing penetration of coconut water uses in this region. Changing consumer preference fueled by high disposable income is another factor propelling the regional market growth.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/coconut-products-market

Further key findings from the report suggest:

In terms of revenue, coconut water is projected to ascend at a CAGR of 20.3% over the forecast years
Oil segment led the coconut products market due to various applications of the product in healthcare, personal care, cosmetics, and food and beverages
China followed by U.S. and Netherlands were the major importers of coconut oil in 2018
Major exporters of coconut and its products are Indonesia, Philippines, India, and Brazil. Brazil was the major exporter for the European countries till 2014. However, due to increasing demand, Philippines also exports to European countries on a large scale.

Gluten Free Sugar Syrup Market Size Worth $1.44 Billion By 2025

The global gluten free sugar syrup market size is expected to reach USD 1.44 billion by 2025, according to a new report by Grand View Research, Inc. It is anticipated to expand at a CAGR of 6.31% during the forecast period. Major factor attributing the growth is the growing number of gluten intolerant people. Consumer awareness regarding healthy living lifestyle is also attributed to the growth. People are omitting gluten rich foods from their diets to avoid diseases like Irritable Bowel Syndrome (IBS) and celiac diseases among others. By 2018, more than 170 million global population was suffering from celiac diseases, driving consumers to opt for gluten free foods and beverages.

Glucose syrup category was valued to be the largest market accounting for 47.21% of the global market in 2018. It is used to help balance sweetness, enhance flavors, and extend shelf life. Some of the key glucose syrup manufacturers are Cargill, Incorporated, SWEET ADDITIONS, LLC, and Tate & Lyle. Maple syrup is the second largest segment in the global market. This is used as an ingredient in a packaged food or poured on pancakes or oatmeal. Quebec, Canada accounted for 71% of the global maple harvest due to its soil capacity.

Industrial category was valued to be the largest application by accounting over 60% of market share in 2018. Growing consumer awareness regarding gluten free foods is driving companies to use gluten free sugar syrup as an ingredient. Companies are expanding their product line for this category. For instance, The Coca Cola Company has introduced Coke Zero, Diet Coke, Coca-Cola Classic, and other gluten free products.

Direct human consumption category accounted for around 37.67% of the global gluten free sugar syrup market in 2018. It is used to prepare different dishes and cocktails. Under this category independent health store sub category is expected to expand at a CAGR of 8.72% from 2019 to 2025. Consumers prefer this independent health store category due to product varieties. Employee training programs to boost sales is anticipated to further drive the product demand over the forecast period. It has been observed that the U.S. base health stores are operating in online and offline markets to meet the customer demand, for instance, The Better Health Store, The Vitamin Shoppe, and others.

North America is the largest consumer of gluten free sugar product. Around 3.5 million U.S. based consumers are gluten intolerant, driving the market growth. Consumer awareness about celiac disease and the rising trend of leading a healthy lifestyle is driving more people to consume gluten-free diet. Europe is expected to be the fastest growing market with a CAGR of 7.29% from 2019 to 2025. Growing consumer awareness about IBS is attributed to the regional growth.

The market is competitive in nature with the presence of many small and large brands. Some of the major companies are B&G Foods, Inc.; MONIN INCORPORATED; Wholesome Sweeteners, Inc.; CANADIAN ORGANIC MAPLE; Börger GmbH; Skinny Mix; Tereos; and others.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/gluten-free-sugar-syrup-market

Further key findings from the report suggest:

In product segment, corn syrup category is projected to ascend at a CAGR of 7.83% from 2019 to 2025
Glucose syrup product led with an overall market share of 47.21% in 2018
Industrial category was the largest application by accounting a market share of 62.33% in 2018
North America led the global gluten free sugar syrup market in 2018 with a market share of 41.3%
Growing consumer awareness regarding healthy lifestyle is driving the growth
The market is highly competitive in nature with the main players including MONIN INCORPORATED; Wholesome Sweeteners, Inc.; CANADIAN ORGANIC MAPLE; Börger GmbH; and Blue Ocean Biotech
Various manufacturers are concentrating on expanding their product line to increase their customer base

Sports Drink Market Size Worth $29.9 Billion By 2025

The global sports drink market size is expected to reach USD 29.9 billion by 2025, according to a new report by Grand View Research, Inc., expanding at a CAGR of 4.3% over the forecast period. Sports drinks contain various constituents including electrolytes, energy, and water that can be consumed by athletes before, during, or after a competition or training. Growing demand for such drinks among individuals engaged in various physical activities is one of the major factors driving the market. In addition, rising health awareness among the younger population is expected to fuel the market growth.

Beautiful young woman drinking water and cooling off after her running training at the park

Rising consumer preference for sports beverages over sodas and other carbonated drinks owing to their respective association with sports and fitness activities. Despite the fact that these beverages were originally made for athletes and sportspersons, they have gained popularity among the common population as anytime drinks or energy drinks, especially among the teenagers and younger adults.

Taking up the opportunity of the popularity of sports beverages among teenagers and adults, manufacturers across the world are targeting these age groups. They are focusing on innovation of new flavors and addition of value to their products by including more health benefits, in order to widen their product portfolio. Furthermore, increase in the number of health clubs and fitness centers are expected to propel the growth of the target market.

In terms of revenue, North America held the largest market share of 40.3% in 2018, owing to growing trend of athleticism and rising concerns over health. Countries in Asia Pacific such as China, India, and Japan are anticipated to hold huge potential for the market growth, considering the presence of a large young population. European countries such as Germany are considered to be the major markets for sports drinks.

Consumer preference for organic and natural products owing to lesser side effects associated with them, is anticipated to have a negative impact on the market growth. Nonetheless, rising demand for these energy beverages with natural ingredients, such as natural sweeteners, is expected to bring up the sales of the market.

Evolution of the retails including supermarkets and hypermarkets, in addition to growing trend of online shopping and booming food and beverage industry, is expected to positively impact the market growth. Among all the distribution channels, retail and supermarkets account for a prominent share in the market due to rising convenience and growing demand for bulk purchases among consumers.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/sports-drink-market

Further key findings from the study suggest:

The hypertonic product segment is projected to expand at a CAGR of 4.6% over the forecast period. The isotonic segment dominated the market with a share of 39.5% in 2018
North America dominated the global sports drink market in 2018, accounting for 40.3% share of the overall revenue. This trend is projected to continue over the next few years
Countries such as Germany are considered to be the major markets for sports drinks, due to high disposable income of the consumers, followed by India, China, and Japan
The industry is highly competitive due to presence of the main players including PepsiCo, Coca-Cola, Sportade, Pocari, 100Plus, and Lucozade
Various manufacturers are focusing on new product launches, capacity expansion, and product portfolio extension to estimate existing and future demand patterns from upcoming application segments.